Kim Moran

Kim Moran is Head of U.S. Rare Diseases, where she oversees the rare disease commercial organization in the U.S., preparing for future launches and building the strategy for our entry into multiple rare diseases. Kim’s career began in rare, working in myasthenia gravis, and she believes through our deep understanding of patients and their needs, we have a responsibility to take risks to deliver for them. Over her nearly 15 years at UCB, she’s seen the organization grow and evolve, giving us the opportunity to gain closer proximity to patients, understand their unmet needs, and deliver unique solutions, including through digital pathways.